Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Trevi Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +9 vs. Q1 2022
- Shares held
- 28.8M
- +21.6M (+301.3%) vs. Q1 2022
- Total value
- $80.8M
- +$47.9M (+145.6%) vs. Q1 2022
- New holders
- 13
- 12 more added
- Sold out
- 4
- 5 more reduced
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 11,373,174 | $32.0M | 1.64% | +11,370,376+406,375.1% | Added |
| TPG GP A, LLC | 4,324,883 | $12.2M | 0.19% | −500,000−10.4% | Reduced |
| VR Adviser, LLC | 3,050,022 | $8.57M | 1.69% | +3,050,022 | New |
| MAI Capital Management | 2,040,009 | $5.73M | 0.11% | +498,538+32.3% | Added |
| Rubric Capital Management LP | 1,778,420 | $5.00M | 0.26% | +1,778,420 | New |
| Fairmount Funds Management LLC | 1,624,389 | $4.57M | 1.04% | +1,624,389 | New |
| Altium Capital Management LP | 1,284,000 | $3.61M | 1.53% | +1,284,000 | New |
| Frazier Life Sciences Management, L.P. | 1,171,627 | $3.29M | 0.31% | +1,171,627 | New |
| Armistice Capital, LLC | 416,000 | $1.17M | 0.03% | +416,000 | New |
| EAM Investors, LLC | 373,243 | $1.05M | 0.26% | +373,243 | New |
| Vanguard Group Inc | 236,940 | $666.0K | 0.00% | +84,109+55.0% | Added |
| Geode Capital Management, LLC | 195,146 | $548.0K | 0.00% | +122,402+168.3% | Added |
| Renaissance Technologies LLC | 151,500 | $426.0K | 0.00% | +35,500+30.6% | Added |
| J. Goldman & Co LP | 135,000 | $379.0K | 0.03% | +135,000 | New |
| Bridgeway Capital Management, LLC | 102,600 | $288.0K | 0.01% | +27,600+36.8% | Added |
| WealthTrust Axiom LLC | 93,500 | $262.0K | 0.09% | −5,000−5.1% | Reduced |
| FMR LLC | 83,225 | $234.0K | 0.00% | +83,225 | New |
| Millennium Management LLC | 66,183 | $186.0K | 0.00% | −18,697−22.0% | Reduced |
| BlackRock Inc. | 57,494 | $161.0K | 0.00% | +24,055+71.9% | Added |
| Northern Trust Corp | 46,298 | $130.0K | 0.00% | +34,884+305.6% | Added |
| State Street Corp | 39,842 | $112.0K | 0.00% | +3,000+8.1% | Added |
| Acuta Capital Partners, LLC | 35,000 | $98.0K | 0.05% | +35,000 | New |
| United Bank | 28,450 | $80.0K | 0.01% | +1,750+6.6% | Added |
| Charles Schwab Investment Management Inc | 12,557 | $36.0K | 0.00% | +12,557 | New |
| LPL Financial LLC | 10,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| FNY Investment Advisers, LLC | 7,986 | $22.0K | 0.02% | +7,986 | New |
| UBS Group AG | 4,771 | $13.0K | 0.00% | +3,147+193.8% | Added |
| Tower Research Capital LLC (TRC) | 3,874 | $11.0K | 0.00% | −5,603−59.1% | Reduced |
| First Manhattan Co | 2,500 | $7.00K | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 1,700 | $5.00K | 0.00% | +1,700 | New |
| Curi Capital | 998 | $3.00K | 0.00% | −3,746−79.0% | Reduced |
| Wells Fargo & Company | 166 | $0 | 0.00% | +93+127.4% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −23,402−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,055−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Morgan Stanley | 0 | $0 | 0.00% | −589−100.0% | Sold out |